Pacira Pharmaceuticals, Inc. 4
4 · Pacira Pharmaceuticals, Inc. · Filed May 4, 2016
Insider Transaction Report
Form 4
Weiland Robert J.
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-05-03+40,000→ 40,000 totalExercise: $51.54Exp: 2026-05-03→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.